Why is QIAGEN NV ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.91 times
2
Poor long term growth as Operating profit has grown by an annual rate 5.15% of over the last 5 years
3
Positive results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD 675.04 MM
- ROCE(HY) Highest at 10.81%
- INTEREST COVERAGE RATIO(Q) Highest at 2,438.55
4
With ROCE of 13.55%, it has a very expensive valuation with a 2.70 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -4.29%, its profits have risen by 32.2% ; the PEG ratio of the company is 0.6
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -4.29% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to QIAGEN NV should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is QIAGEN NV for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
QIAGEN NV
-0.9%
-0.06
25.64%
S&P 500
18.34%
0.70
20.15%
Quality key factors
Factor
Value
Sales Growth (5y)
2.25%
EBIT Growth (5y)
-0.60%
EBIT to Interest (avg)
10.44
Debt to EBITDA (avg)
0.91
Net Debt to Equity (avg)
0.13
Sales to Capital Employed (avg)
0.39
Tax Ratio
32.32%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.89%
ROCE (avg)
13.81%
ROE (avg)
14.15%
Valuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
2.25
EV to EBIT
17.35
EV to EBITDA
13.59
EV to Capital Employed
2.09
EV to Sales
4.33
PEG Ratio
11.05
Dividend Yield
NA
ROCE (Latest)
12.04%
ROE (Latest)
12.51%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
5What is working for the Company
ROCE(HY)
Highest at 11.57%
INVENTORY TURNOVER RATIO(HY)
Highest at 2.68 times
NET SALES(Q)
Highest at USD 540.42 MM
-6What is not working for the Company
INTEREST(Q)
At USD 10.14 MM has Grown at 23.38%
INTEREST COVERAGE RATIO(Q)
Lowest at 1,202.09
OPERATING PROFIT(Q)
Lowest at USD 121.88 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 22.55 %
Here's what is working for QIAGEN NV
Inventory Turnover Ratio
Highest at 2.68 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at USD 540.42 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Here's what is not working for QIAGEN NV
Interest
At USD 10.14 MM has Grown at 23.38%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest Coverage Ratio
Lowest at 1,202.09
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at USD 121.88 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at 22.55 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales






